+++
COLITIS, CLOSTRIDIOIDES DIFFICILE
++
++
+++
Prevention Recommendations
++
– Develop antibiotic stewardship programs to minimize the frequency and duration of high-risk antibiotic therapy.
– Place patients with suspected C. difficile infection (CDI) preemptively on contact precautions pending the C. difficile test results.
– Maintain contact precautions for at least 48 h after diarrhea has resolved.
– Perform hand hygiene before and after contact of a patient with CDI and after removing gloves with either soap or water.
– Use gloves and gowns on entry to the room of a patient with known or suspected CDI and remove gowns and gloves before leaving the patient’s room.
– Prevent transmission by using single-use disposable equipment. Thoroughly clean and disinfect reusable medical equipment, preferentially with a sporicidal disinfectant. Dedicated nondisposable equipment should be kept in the patient’s room.
– Disinfect environmental surfaces using an Environmental Protective Agency (EPA)–registered disinfectant with C. difficile sporicidal label claim or minimum chlorine concentration of 5000 ppm.
– Although there is an epidemiological association between proton pump inhibitor (PPI) use and CDI, there is insufficient evidence for discontinuation of PPIs as a measure for preventing CDI.
– Although there is moderate evidence that probiotics containing Lactobacillus rhamnosus GG and Saccharomyces boulardii decrease the incidence of antibiotic-associated diarrhea, there is insufficient data to recommend administration of probiotics for primary prevention of CDI. Still, short-term use of probiotics appears to be safe and effective when used along with antibiotics in patients who are not immunocompromised or severely ill.
++
– Am J Gastroenterol. 2013;108(4):478.
– Clin Infect Dis. 2018;66(7):e1-e48.
– Cochrane Database Syst Rev. 2017;12:CD006095.
+++
ENDOCARDITIS, INFECTIOUS
++
Adults at risk for infectious endocarditis.
++
► AHA 2007, AHA/ACC 2014, AHA/ACC 2017, AAPD 2014
+++
Prevention Recommendations
++
– Maintain optimal oral health and hygiene. This is more important in reducing the risk of infective endocarditis (IE) than prophylactic antibiotics for dental procedures.
– There is insufficient evidence to support the use of topical antiseptics for IE prevention.
– Prevent rheumatic fever by promptly recognizing and treating streptococcal pharyngitis.
– The effectiveness of antibiotic prophylaxis in preventing IE in patients undergoing dental procedures is unknown.
– Do not use antibiotic prophylaxis for mitral valve prolapse (MVP), rheumatic heart disease (RHD), or most cases of congenital heart disease (CHD).1
– Offer IE prophylaxis2 only for patients with underlying cardiac conditions (patients with prosthetic valves,3 previous history of IE, certain cardiac transplant recipients,4 and selected patients with CHD and residual defects) who will undergo selected dental, respiratory, GI, GU, skin, and soft tissue procedures.